IPG Photonics (IPGP) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
17 Dec, 2025Executive summary
Q4 2024 revenue reached $234.3 million, at the high end of guidance, but down 22% year-over-year due to weak industrial, automotive, and medical demand, with growth in advanced and emerging applications.
Gross margin improved to 38.6%, up 40 basis points year-over-year, aided by cost reductions and lower product, shipping, and tariff costs, despite lower manufacturing absorption.
Net income for Q4 was $7.8 million, with EPS of $0.18, both down sharply from prior year due to unusual tax items and lower sales.
Free cash flow and operating cash flow remained strong, with $930 million in cash and no debt, providing flexibility for strategic investments.
Strategic focus is on cost reduction, product innovation, and targeted investments in high-growth areas such as urology, micromachining, and advanced applications.
Financial highlights
Q4 revenue was $234.3 million, down 22% year-over-year, up 1% sequentially, with foreign currency reducing revenue by 1%.
Gross margin was 38.6%, up from 38.2% year-over-year.
GAAP operating income was $14 million; operating margin 6.0% (down from 9.6% YoY); net income $7.8 million; EPS $0.18 (down 80% YoY).
Effective tax rate was 64% due to unusual tax items, including repatriation of cash, reducing EPS by $0.08.
Cash from operations was $74 million; capital expenditures were $23 million in Q4 and $98.5 million for the year; $57 million spent on share repurchases in Q4, $344 million for the year.
Outlook and guidance
Q1 2025 revenue expected between $210 million and $240 million; gross margin guidance is 36%-39%.
Operating expenses projected at $82-$84 million in Q1, increasing further in Q2 and remaining elevated through 2025.
Adjusted EPS for Q1 expected in the range of $0.05-$0.35; adjusted EBITDA between $19 million-$35 million.
2025 CapEx expected at $105-$115 million, mainly for manufacturing capacity in Germany.
Free cash flow expected to improve significantly in 2026 after current investment cycle.
Latest events from IPG Photonics
- Growth driven by innovation, new markets, and strong financials positions the business for expansion.IPGP
47th Annual Raymond James Institutional Investor Conference2 Mar 2026 - Q4 revenue up 17% year-over-year, with strong gains in medical and advanced applications.IPGP
Q4 202512 Feb 2026 - Q2 revenue fell 24% YoY to $257.6M–$258M; cash flow strong despite weak demand.IPGP
Q2 20242 Feb 2026 - Transitioning from legacy cutting to high-growth welding, EV, and medical markets, with robust innovation.IPGP
The Stifel 2024 Cross Sector Insight Conference31 Jan 2026 - Q3 revenue dropped 23% and net loss hit $233.6M, but adjusted EPS was $0.29.IPGP
Q3 202418 Jan 2026 - Industrial laser innovation, market diversification, and stable financials drive future growth.IPGP
Bank of America Global Industrials Conference 202526 Dec 2025 - Poised for growth with strong cash flow, margin recovery, and expanding opportunities in new markets.IPGP
Raymond James 46th Annual Institutional Investors Conference23 Dec 2025 - Shareholders to vote on directors, pay, new incentive plan, and auditor amid strategic shifts.IPGP
Proxy Filing1 Dec 2025 - Director elections, executive pay, incentive plan, and auditor ratification up for vote May 20, 2025.IPGP
Proxy Filing1 Dec 2025